Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE998
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,487
Award facts
- Contract value 100% obligated
- $29,486.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,486.92 to AmerisourceBergen Drug Corp on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This IDC serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the efficient delivery model established under DLA's pharmaceutical supply chain framework, enabling the agency to procure essential medical commodities through an established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DU26FE998?
SPE2DU26FE998 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DU26FE998 worth?
The government has obligated $29,487 on SPE2DU26FE998.
Is contract SPE2DU26FE998 an order under another contract?
Yes. SPE2DU26FE998 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE998 competed?
The extent of competition for SPE2DU26FE998 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award